Protara Therapeutics, Inc. Gain (Loss) on Disposition of Assets
Protara Therapeutics, Inc. (TARA) reported Gain (Loss) on Disposition of Assets of $65.00 thousand for the 12-month period ending 2013-12-31, per its 10-K filed 2016-03-14.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets1 · last filed 2016-03-14
- Protara Therapeutics, Inc. gain (loss) on disposition of assets for the quarter ending 2013-12-31 was $58.00K.
- Protara Therapeutics, Inc. gain (loss) on disposition of assets for fiscal 2013 was $65.00K, a 1200.00% increase from fiscal 2012.
- Protara Therapeutics, Inc. gain (loss) on disposition of assets for fiscal 2012 was $5.00K.
| Period end | Gain (Loss) on Disposition of Assets 3 month | Gain (Loss) on Disposition of Assets 9 month | Gain (Loss) on Disposition of Assets 12 month |
|---|---|---|---|
| 2013-12-31 | $58.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | $65.00K 10-K · filed 2016-03-14 | |
| 2013-09-30 | $7.00K 10-Q · filed 2014-11-25 | ||
| 2012-12-31 | $5.00K 10-K · filed 2015-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |